Fig. 2
From: Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Functional recovery of patients in the double-blind proof-of-concept trial. (A) NIH stroke scale. (B) Scandinavian stroke scale. Data represent mean ± SEM (n = 19 for placebo, n = 21 for rhEPO). p-Values according to multiple regression analysis. Dead patients received the worst possible score.